And as a reminder, both of these stocks are down since the beginning of this year due to disappointing anti-obesity treatment growth and guidance, with Novo shares steadily losing ground since early 2024, shortly after Lilly's Zepbound first became available, setting off what would eventually turn into a price war
USDC on Solana is recommended for lowest fees
Injectable semaglutide offers the broadest range of benefits, with FDA approval for weight loss, type 2 diabetes management, and heart health protection
The GLP-1 Revolution Comes to the Mountains GLP-1 receptor agonists represent the most significant breakthrough in medical weight loss since bariatric surgery
For proper reconstitution, the following laboratory supplies are necessary: Reconstitution solution Syringes for extracting from the vials Alcohol pads for sterilization To ensure accurate and safe handling of our research products
That was the case with shortages of GLP1 drugs from 2022 to several months ago, to meet the high demand